TRIGLAV INVESTMENTS, D.O.O.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 2056690
LJUBLJANA, 2A
Position in BMRN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$944,130
+$12,045 QoQ
Shares Held
16,500
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#282
of 561 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRIGLAV INVESTMENTS, D.O.O. holds $5,956,452 across 7 Biotechnology names. BMRN ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,000 | $1,870,620 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,450 | $1,713,718 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
16,500 | $944,130 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
70,053 | $397,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,102 | $393,662 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
3,000 | $367,740 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,115 | $268,681 |
All Filings in BMRN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $944,130 | 16,500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $932,085 | 16,500 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $980,595 | 16,500 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $893,640 | 16,500 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $907,005 | 16,500 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,166,385 | 16,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,084,545 | 16,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||